VIB VZW;Centre Hospitalier Regional Universitaire de Montpellier;Universiteit Gent;Centre National de la Recherche Scientifique;Universite Montpellier 2
The present invention relates to a fusion protein comprising at least two cytokines, of which at least one is a modified cytokine with a strongly reduced binding affinity to its receptor, or to one of its receptors. Preferably, both cytokines are connected by a linker, preferably a GGS linker. The invention relates further to said fusion protein for use in treatment of diseases.